CCL20: Difference between revisions
CSV import |
CSV import |
||
| Line 28: | Line 28: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 05:34, 17 March 2025
CCL20 or Chemokine (C-C motif) ligand 20 is a small cytokine belonging to the CC chemokine family that is also known as liver activation regulated chemokine (LARC), macrophage inflammatory protein-3 (MIP3A), and Exodus-1. CCL20 is thought to play a role in the immune response by attracting leukocytes to the site of inflammation.
Function[edit]
CCL20 is expressed in the liver, lungs, lymph nodes and peripheral blood leukocytes. It is strongly upregulated by inflammatory signals, and downregulated by the anti-inflammatory cytokine interleukin 10.
CCL20 attracts certain cells of the immune system, including dendritic cells, effector/memory T-cells and B cells. It is thought to play a role in the development of lymphoid tissue by attracting these cells to the site of inflammation.
Clinical significance[edit]
CCL20 has been implicated in a number of inflammatory and autoimmune diseases, including rheumatoid arthritis, psoriasis, and inflammatory bowel disease. It is also thought to play a role in the progression of certain types of cancer, including colorectal cancer and breast cancer.
See also[edit]
References[edit]
<references />


